{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:25:08Z","timestamp":1791141908478,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.brainres.2006.06.001","type":"journal-article","created":{"date-parts":[[2006,7,7]],"date-time":"2006-07-07T13:52:06Z","timestamp":1152280326000},"page":"199-205","source":"Crossref","is-referenced-by-count":28,"title":["Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice"],"prefix":"10.1016","volume":"1107","author":[{"given":"Ana","family":"Cabranes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Pryce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Fern\u00e1ndez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2006.06.001_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/cimm.1993.1031","article-title":"Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB\/H mouse","volume":"146","author":"Allen","year":"1993","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.brainres.2006.06.001_bib2","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1523\/JNEUROSCI.23-07-02511.2003","article-title":"Therapeutic action of cannabinoids in a murine model of multiple sclerosis","volume":"23","author":"Ar\u00e9valo-Martin","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2006.06.001_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/13543784.12.4.561","article-title":"The therapeutic potential of cannabis in multiple sclerosis","volume":"12","author":"Baker","year":"2003","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.brainres.2006.06.001_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-5728(90)90019-J","article-title":"Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice","volume":"28","author":"Baker","year":"1990","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainres.2006.06.001_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35003583","article-title":"Cannabinoids control spasticity and tremor in a multiple sclerosis model","volume":"404","author":"Baker","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2006.06.001_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1096\/fj.00-0399fje","article-title":"Endocannabinoids control spasticity in experimental multiple sclerosis","volume":"15","author":"Baker","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2006.06.001_bib7","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1111\/j.1552-6569.2004.tb00277.x","article-title":"Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis","volume":"14","author":"Benedict","year":"2004","journal-title":"J. Neuroimag."},{"key":"10.1016\/j.brainres.2006.06.001_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/syn.1075","article-title":"Changes in cannabinoid CB1 receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis","volume":"41","author":"Berrendero","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2006.06.001_bib9","series-title":"Therapeutic Uses of Cannabis","author":"British Medical Association Report","year":"1997"},{"key":"10.1016\/j.brainres.2006.06.001_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(02)01369-9","article-title":"Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1\/CB2 receptors","volume":"439","author":"Brooks","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2006.06.001_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2005.03.002","article-title":"Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and\/or vanilloid receptors in a rat model of multiple sclerosis","volume":"20","author":"Cabranes","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2006.06.001_bib12","first-page":"44","article-title":"The perceived effects of smoked cannabis on patient with multiple sclerosis","volume":"38","author":"Consroe","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2006.06.001_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2003.11.027","article-title":"In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake","volume":"484","author":"de Lago","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2006.06.001_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.euroneuro.2005.06.001","article-title":"UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay\/arrest the progression of different motor-related disorders","volume":"16","author":"de Lago","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2006.06.001_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","article-title":"The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells","volume":"49","author":"Eljaschewitsch","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2006.06.001_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/070674370404900302","article-title":"The neuropsychiatry of multiple sclerosis","volume":"49","author":"Feinstein","year":"2004","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.brainres.2006.06.001_bib17","series-title":"Cannabinoids as Therapeutics (MDT)","first-page":"79","article-title":"Cannabinoids in neurodegeneration and neuroprotection","author":"Fern\u00e1ndez-Ruiz","year":"2005"},{"key":"10.1016\/j.brainres.2006.06.001_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2006.06.001_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuroscience.2005.02.045","article-title":"Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation","volume":"134","author":"Jackson","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2006.06.001_bib20","series-title":"Stereotaxic Atlas of the Brain of the Mouse","author":"Lehmann","year":"1974"},{"key":"10.1016\/j.brainres.2006.06.001_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0165-5728(89)90075-1","article-title":"\u03949-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis","volume":"23","author":"Lyman","year":"1989","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainres.2006.06.001_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/10408369509084683","article-title":"Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis","volume":"32","author":"Martin","year":"1995","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.brainres.2006.06.001_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0163-7258(02)00255-3","article-title":"Cannabinoids and multiple sclerosis","volume":"95","author":"Pertwee","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2006.06.001_bib24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/bmj.321.7259.490","article-title":"Drug treatment of multiple sclerosis","volume":"321","author":"Polman","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.brainres.2006.06.001_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.tins.2005.03.006","article-title":"Emerging properties of cannabinoid medicines in management of multiple sclerosis","volume":"28","author":"Pryce","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2006.06.001_bib26","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/brain\/awg224","article-title":"Cannabinoids inhibit neurodegeneration in models of multiple sclerosis","volume":"126","author":"Pryce","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2006.06.001_bib27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","article-title":"Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis","volume":"65","author":"Rog","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2006.06.001_bib28","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/00001756-199412000-00022","article-title":"Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study","volume":"5","author":"Rubino","year":"1994","journal-title":"NeuroReport"},{"key":"10.1016\/j.brainres.2006.06.001_bib29","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1073\/pnas.92.16.7242","article-title":"In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5\u2032-[\u03b3-[35S]thio]-triphosphate binding","volume":"92","author":"Sim","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2006.06.001_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0162-3109(94)90056-6","article-title":"Suppression of experimental autoimmune encephalomyelitis by cannabinoids","volume":"28","author":"Wirguin","year":"1994","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.brainres.2006.06.001_bib31","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1073\/pnas.0510418103","article-title":"Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection","volume":"103","author":"Witting","year":"2006","journal-title":"PNAS (USA)"},{"key":"10.1016\/j.brainres.2006.06.001_bib32","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","article-title":"Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial","volume":"362","author":"Zajicek","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2006.06.001_bib33","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/jnnp.2005.070136","article-title":"Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12\u00a0months follow up","volume":"76","author":"Zajicek","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899306016672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899306016672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T17:41:05Z","timestamp":1549647665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899306016672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0006899306016672"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2006.06.001","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}